位置:首页 > 蛋白库 > BIUH_RHIL3
BIUH_RHIL3
ID   BIUH_RHIL3              Reviewed;         233 AA.
AC   Q1M7F4;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 1.
DT   03-AUG-2022, entry version 83.
DE   RecName: Full=Biuret amidohydrolase {ECO:0000303|PubMed:29425231};
DE            EC=3.5.1.84 {ECO:0000269|PubMed:21897878, ECO:0000269|PubMed:29425231};
DE   AltName: Full=Biuret hydrolase {ECO:0000303|PubMed:21897878};
GN   Name=biuH {ECO:0000303|PubMed:29425231};
GN   ORFNames=pRL100352 {ECO:0000312|EMBL:CAK10578.1};
OS   Rhizobium leguminosarum bv. viciae (strain 3841).
OG   Plasmid pRL10 {ECO:0000312|EMBL:CAK10578.1}.
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Hyphomicrobiales;
OC   Rhizobiaceae; Rhizobium/Agrobacterium group; Rhizobium.
OX   NCBI_TaxID=216596;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=3841;
RX   PubMed=16640791; DOI=10.1186/gb-2006-7-4-r34;
RA   Young J.P.W., Crossman L.C., Johnston A.W.B., Thomson N.R., Ghazoui Z.F.,
RA   Hull K.H., Wexler M., Curson A.R.J., Todd J.D., Poole P.S., Mauchline T.H.,
RA   East A.K., Quail M.A., Churcher C., Arrowsmith C., Cherevach I.,
RA   Chillingworth T., Clarke K., Cronin A., Davis P., Fraser A., Hance Z.,
RA   Hauser H., Jagels K., Moule S., Mungall K., Norbertczak H.,
RA   Rabbinowitsch E., Sanders M., Simmonds M., Whitehead S., Parkhill J.;
RT   "The genome of Rhizobium leguminosarum has recognizable core and accessory
RT   components.";
RL   Genome Biol. 7:R34.1-R34.20(2006).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RC   STRAIN=3841;
RX   PubMed=21897878; DOI=10.1021/cs200295n;
RA   Cameron S.M., Durchschein K., Richman J.E., Sadowsky M.J., Wackett L.P.;
RT   "A new family of biuret hydrolases involved in S-triazine ring
RT   metabolism.";
RL   ACS Catal. 2011:1075-1082(2011).
RN   [3] {ECO:0007744|PDB:5BK6, ECO:0007744|PDB:6AZN, ECO:0007744|PDB:6AZO, ECO:0007744|PDB:6AZQ, ECO:0007744|PDB:6AZS}
RP   X-RAY CRYSTALLOGRAPHY (1.59 ANGSTROMS) OF WILD-TYPE; MUTANTS ALA-142;
RP   HIS-142; SER-175 AND MUTANT SER-175 IN COMPLEX WITH BIURET, FUNCTION,
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, ACTIVE SITES, AND MUTAGENESIS OF ASP-36; PHE-41; LYS-142; LYS-145;
RP   CYS-175 AND GLN-215.
RC   STRAIN=3841;
RX   PubMed=29425231; DOI=10.1371/journal.pone.0192736;
RA   Esquirol L., Peat T.S., Wilding M., Lucent D., French N.G., Hartley C.J.,
RA   Newman J., Scott C.;
RT   "Structural and biochemical characterization of the biuret hydrolase (BiuH)
RT   from the cyanuric acid catabolism pathway of Rhizobium leguminasorum bv.
RT   viciae 3841.";
RL   PLoS ONE 13:e0192736-e0192736(2018).
CC   -!- FUNCTION: Involved in the degradation of cyanuric acid, an intermediate
CC       in the degradation of s-triazide herbicides such as atrazine
CC       (PubMed:21897878). Catalyzes the hydrolysis of biuret to urea-1-
CC       carboxylate (allophanate) and ammonia (PubMed:21897878,
CC       PubMed:29425231). The substrate, biuret, is formed by the spontaneous
CC       decarboxylation of carboxybiuret (PubMed:21897878).
CC       {ECO:0000269|PubMed:21897878, ECO:0000269|PubMed:29425231}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=biuret + H2O = NH4(+) + urea-1-carboxylate;
CC         Xref=Rhea:RHEA:17525, ChEBI:CHEBI:15377, ChEBI:CHEBI:15832,
CC         ChEBI:CHEBI:18138, ChEBI:CHEBI:28938; EC=3.5.1.84;
CC         Evidence={ECO:0000269|PubMed:21897878, ECO:0000269|PubMed:29425231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17526;
CC         Evidence={ECO:0000269|PubMed:21897878, ECO:0000269|PubMed:29425231};
CC   -!- ACTIVITY REGULATION: Strongly inhibited by the sulfhydryl-modifying
CC       reagents N-ethylmaleimide and iodoacetamide (PubMed:21897878).
CC       Inhibited by the substrate analog N-carbamoyl aspartic acid
CC       (PubMed:29425231). {ECO:0000269|PubMed:21897878,
CC       ECO:0000269|PubMed:29425231}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=23 uM for biuret {ECO:0000269|PubMed:21897878};
CC         KM=79 uM for biuret {ECO:0000269|PubMed:29425231};
CC         Note=kcat is 4.0 sec(-1) (PubMed:21897878). kcat is 11.9 sec(-1)
CC         (PubMed:29425231). {ECO:0000269|PubMed:21897878,
CC         ECO:0000269|PubMed:29425231};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:21897878};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:29425231}.
CC   -!- SIMILARITY: Belongs to the isochorismatase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM236084; CAK10578.1; -; Genomic_DNA.
DR   RefSeq; WP_011654379.1; NC_008381.1.
DR   PDB; 5BK6; X-ray; 1.59 A; A/B/C/D=1-233.
DR   PDB; 6AZN; X-ray; 1.75 A; A/B/C/D/F/G/H/I=1-233.
DR   PDB; 6AZO; X-ray; 2.46 A; A/B/C/D=1-233.
DR   PDB; 6AZQ; X-ray; 2.22 A; A/B/C/D/E/F/G/H=1-233.
DR   PDB; 6AZS; X-ray; 1.59 A; A/B/C/D=1-233.
DR   PDBsum; 5BK6; -.
DR   PDBsum; 6AZN; -.
DR   PDBsum; 6AZO; -.
DR   PDBsum; 6AZQ; -.
DR   PDBsum; 6AZS; -.
DR   SMR; Q1M7F4; -.
DR   EnsemblBacteria; CAK10578; CAK10578; pRL100352.
DR   KEGG; rle:pRL100352; -.
DR   HOGENOM; CLU_068979_8_0_5; -.
DR   OMA; IIIDMQT; -.
DR   OrthoDB; 1442962at2; -.
DR   BioCyc; MetaCyc:MON-20658; -.
DR   BRENDA; 3.5.1.84; 5344.
DR   Proteomes; UP000006575; Plasmid pRL10.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.850; -; 1.
DR   InterPro; IPR000868; Isochorismatase-like.
DR   InterPro; IPR036380; Isochorismatase-like_sf.
DR   Pfam; PF00857; Isochorismatase; 1.
DR   SUPFAM; SSF52499; SSF52499; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Plasmid.
FT   CHAIN           1..233
FT                   /note="Biuret amidohydrolase"
FT                   /id="PRO_0000455209"
FT   ACT_SITE        36
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:29425231"
FT   ACT_SITE        142
FT                   /evidence="ECO:0000305|PubMed:29425231"
FT   ACT_SITE        175
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305|PubMed:29425231"
FT   BINDING         84
FT                   /ligand="biuret"
FT                   /ligand_id="ChEBI:CHEBI:18138"
FT                   /evidence="ECO:0000269|PubMed:29425231,
FT                   ECO:0007744|PDB:6AZQ"
FT   BINDING         145
FT                   /ligand="biuret"
FT                   /ligand_id="ChEBI:CHEBI:18138"
FT                   /evidence="ECO:0000269|PubMed:29425231,
FT                   ECO:0007744|PDB:6AZQ"
FT   BINDING         170..175
FT                   /ligand="biuret"
FT                   /ligand_id="ChEBI:CHEBI:18138"
FT                   /evidence="ECO:0000269|PubMed:29425231,
FT                   ECO:0007744|PDB:6AZQ"
FT   BINDING         215
FT                   /ligand="biuret"
FT                   /ligand_id="ChEBI:CHEBI:18138"
FT                   /evidence="ECO:0000269|PubMed:29425231,
FT                   ECO:0007744|PDB:6AZQ"
FT   MUTAGEN         36
FT                   /note="D->A,E,N,Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         41
FT                   /note="F->A: 540-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         41
FT                   /note="F->L: 713-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         41
FT                   /note="F->W: 73-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         41
FT                   /note="F->Y: 138-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         142
FT                   /note="K->A,H: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         142
FT                   /note="K->R: 297-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         145
FT                   /note="K->A,H,R: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         175
FT                   /note="C->A,S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         215
FT                   /note="Q->A: 419-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         215
FT                   /note="Q->D: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         215
FT                   /note="Q->E: 1300-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
FT   MUTAGEN         215
FT                   /note="Q->N: 38-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29425231"
SQ   SEQUENCE   233 AA;  25540 MW;  29A63B0488251858 CRC64;
     MDAMVETNRH FIDADPYPWP YNGALRPDNT ALIIIDMQTD FCGKGGYVDH MGYDLSLVQA
     PIEPIKRVLA AMRAKGYHII HTREGHRPDL ADLPANKRWR SQRIGAGIGD PGPCGRILTR
     GEPGWDIIPE LYPIEGETII DKPGKGSFCA TDLELVLNQK RIENIILTGI TTDVCVSTTM
     REANDRGYEC LLLEDCCGAT DYGNHLAAIK MVKMQGGVFG SVSNSAALVE ALP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024